SCHEMBL18753490

SCHEMBL18753490

O=C(c1ccc(N[SH](=O)=O)c(F)c1)N1CCN(C(=O)c2cnccn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.45
▸ DPP9 Q86TI2 1/20 0.45
▸ LMNA P02545 1/20 0.42
▸ GBA1 P04062 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ CYP3A4 P08684 5/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ USP2 O75604 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ HIF1A Q16665 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ BCR P11274 1/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753306 0.87 GBA1 (0.44) LMNAGBA1GAACYP3A4CYP1A2
SCHEMBL18753365 0.86 P2RX7 (0.45) DPP4DPP9LMNAGAACYP3A4
SCHEMBL18753305 0.86 L3MBTL1 (0.56) DPP4DPP9GAAMEN1KMT2A
SCHEMBL18753814 0.85 SMN1; SMN2 (0.48) LMNAGBA1GAACYP3A4MEN1
SCHEMBL18753323 0.84 POLB (0.57) DPP4MEN1KMT2AABL1BCR
SCHEMBL22422416 0.84 DPP4 (0.44) DPP4DPP9LMNAGBA1GAA
SCHEMBL18753319 0.83 MGLL (0.51) MEN1KMT2APARP1NAMPT
SCHEMBL18753379 0.81 KMT2A (0.61) LMNAGAAHSD17B10MEN1KMT2A
SCHEMBL18753448 0.77 LMNA (0.51) LMNAGAACYP1A2HSD17B10CYP2C9
SCHEMBL18753373 0.76 ALDH1A1 (0.57) LMNAHSD17B10MEN1KMT2AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-A1 QUINOLINE-8-SULFONAMIDE DERIVATES HAVING AN ANTICANCER ACTIVITY Agios Pharmaceuticals, Inc. (US) 2017-11-08 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback